SynBiotic SE (SBX.DE) XETRA
1.78
+0.056(+3.26%)
Currency In EUR
- General
- Statistics
- Historical Data
- Profile
- Financials
1.78
+0.056(+3.26%)
Currency In EUR
Address
Innere Wiener Str. 14
Munich, 81667
Germany
Phone
49 89 6003 7544
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
55
First IPO Date
January 07, 2021
| Name | Title | Pay | Year Born |
| Rebecca Kruse-Rosetti | ?Head of Finance | 0 | N/A |
| Daniel Kruse | Managing Director | 0 | N/A |
SynBiotic SE engages in the development of medicines and over-the-counter wellness products based on cannabinoids. It focuses on synthetic production of cannabinoids, drug development, nutritional supplements, and cosmetic products. The company was formerly known as Ledgertech SE and changed its name to Ledgertech SE. SynBiotic SE based in Munich, Germany.